P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES: THE MYELODYSPLASTIC SYNDROMES STUDIES IN THE STIMULUS IMMUNO-MYELOID CLINICAL TRIAL PROGRAM
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Reihe/Periodikum: | HemaSphere, Vol 6, Pp 682-683 (2022) |
Verlag/Hrsg.: |
Wolters Kluwer
|
Schlagwörter: | Diseases of the blood and blood-forming organs / RC633-647.5 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26862284 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1097/01.HS9.0000846032.37876.c9 |